Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial
Saip, P., Eralp, Y., Sen, F., Karaca, H., Ozkan, M., Cetin, B., Benekli, M., Kucukoner, M., Isikdogan, A., Un, O., Basaran, G., Onur, H.Volume:
22
Langue:
english
Journal:
The Breast
DOI:
10.1016/j.breast.2013.07.048
Date:
October, 2013
Fichier:
PDF, 232 KB
english, 2013